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Objective: Endovascular procedures have become an integral part of a vascular surgeon’s practice. The exposure of
surgeons to ionizing radiation and other safety issues have not been well studied. We investigated the radiation exposure
of a team of vascular surgeons in an active endovascular unit and compared yearly dosages absorbed by various body parts
among different surgeons. Patients’ radiation exposure was also assessed.
Methods: The radiation absorption of a team of vascular surgeons was prospectively monitored in a 12-month period.
During each endovascular procedure, the effective body, eye, and hand radiation doses of all participating surgeons were
measured by mini-thermoluminescent dosimeters (TLD) attached at the chest level under a lead apron, at the forehead at
eye level, and at the hand. The type of procedure, fluoroscopy machine, fluoroscopy time, and personal and operating
theatre radiation protection devices used in each procedure were also recorded. One TLD was attached to the patient’s
body near the operative site to measure the patient’s dose. The yearly effective body, eye, and hand dose were compared
with the safety limits of radiation for occupational exposure recommended by the International Commission on
Radiation Protection (ICRP). The radiation absorption of various body parts per minute of fluoroscopy was compared
among different surgeons.
Results: A total of 149 consecutive endovascular procedures were performed, including 30 endovascular aortic repairs
(EVAR), 58 arteriograms with and without embolization (AGM), and 61 percutaneous transluminal angioplasty and
stent (PTA/S) procedures. The cumulative fluoroscopy time was 1132 minutes. The median yearly effective body, eye,
and hand dose for the surgeons were 0.20 mSv (range, 0.13 to 0.27 mSv), 0.19 mSv (range, 0.10 to 0.33 mSv) and 0.99
mSv (0.29 to 1.84 mSv) respectively, which were well below the safety limits of the ICRP. The mean body, eye, and hand
dose of the chief surgeon per procedure were highest for EVAR. A significant discrepancy was observed for the average
hand dose per minute of fluoroscopy among different surgeons. The mean radiation absorption of patients who
underwent EVAR, AGM, and PTA/S was 12.7 mSv, 13.6 mSv, and 3.4 mSv, respectively.
Conclusion: With current radiation protection practice, the radiation absorbed by vascular surgeons with a high
endovascular workload did not exceed the safety limits recommended by ICRP. Variations in practice, however, can result
in significant discrepancy of radiation absorption between surgeons. (J Vasc Surg 2007;46:455-9.)The development of endovascular intervention has
been a major advancement in vascular surgery in the last
two decades.1-3 Fluoroscopy is essential to provide image
guidance for endovascular procedures. Vascular surgeons
performing significant numbers of endovascular proce-
dures, as well as their patients, are at risk of exposure to
potentially hazardous ionizing radiation, but radiation
safety data have seldom been documented quantitatively.
This study aims to determine the cumulative amount of
radiation absorbed by surgeons performing various types of
endovascular procedures and the differential absorption by
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during these procedures was also investigated.
METHODS
We prospectively record the radiation absorption of all
surgeons and patients during all fluoroscopy-guided endo-
vascular procedures in a tertiary vascular surgery unit dur-
ing a 12-month period from July 2004 to June 2005. The
surgical staff consisted of four specialist vascular surgeons
(VS 1-4) and one rotating trainee (TR) of a 6-month term.
Fluoroscopy equipment and radiation protection.
All endovascular procedures were performed in the operat-
ing room under mobile fluoroscopy guidance, using the
OEC 9800 (GE Medical Systems, Salt Lake City, Utah) or
BV 29 (Philips, Best, the Netherlands) image intensifier
systems on a carbon-fiber interventional operating table
(US Imaging Tables, New York, NY) equipped with side
lead shields (model 311/DS-004, Kenex, Haelow, Essex,
UK). Additional mobile lead shields (model 326/05,
Kenex) were routinely used above the table for added
protection.
The usual fluoroscopic frame rates used were 8 to 12
frames per second with digital subtraction angiography,
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beams were used during screening and acquisition runs
according to the image quality requirement in different
circumstances. High-level fluoroscopy was not used. Colli-
mation was applied whenever possible, and its application
was decided by the chief surgeon performing the proce-
dure. Personal radiation protection devices included
0.3-mm and 0.5-mm lead aprons, a lead thyroid shield, and
lead eyeglasses.
Role of surgeons. The chief surgeon is responsible for
decision-making as well as manipulating guidewires and
catheters, contrast injection (if hand injection is used), and
delivery of stents or stent grafts. The first and second
assistants (or the supervisor) stand on the side of the chief
surgeon and are responsible for preparation of catheters or
devices, stabilizing the guidewires, and exchange of cathe-
ters or devices. The chief surgeon occupies a position
closest to the fluoroscopy field compared with the assis-
tants.
Radiation absorption measurement. The radiation
absorption of vascular surgeons was measured by the dose
equivalent of the absorbed radiation, which is calculated as
absorbed dose times the quality factor of the radiation
beam. The special unit is rem. The sievert (Sv) is the
International System of Units of dose equivalent (1 rem 
0.01 Sv).
Multiple radiation sensitive mini-thermoluminescent
dosimeters (TLDs) were worn by the chief and assistant
surgeons during all endovascular procedures. The dosime-
ter used was the LiF:Mg,Ti Bicron/Harshaw TLD-100
chips (Harshaw/Bicron, Solon, Ohio). All the TLDs were
calibrated in the laboratory of the Radiation Health Unit,
Department of Health, with a minimal detectable level of
10 Sv. Standard badge TLDs were attached to the chest
level beneath the lead apron for measurement of the effec-
tive body dose under lead. A TLD model EXT-RAD was
applied to the forehead or within lead eyeglasses to measure
the effective dose to the eyes. A third ring-type TLD
(DXT-RAD) was worn on the left index finger to measure
the hand dose. One EXT-RAD TLD was attached to the
main exposure area of each patient for measurement of
their surface entrance dose.
All the TLDs were processed by automated TLD read-
ers Harshaw 6600E or 6600CCD. The type of procedure,
fluoroscopy machine, total fluoroscopy time, types of per-
sonal radiation protection device applied, and the use of
extra radiation shield were recorded.
Data analysis. The cumulative effective dose of all the
surgeons was compared with the safety dose limit recom-
mended by the International Commission on Radiation
Protection (ICRP; Table I) for occupational and public
exposure with respect to different body areas.4 The mean
radiation absorption per procedure and the mean patient
dose for different types of endovascular procedures was
determined. The radiation absorption per minute of fluo-
roscopy time of various body areas was compared among
the different surgeons when they were chief operator to
determine the relationship between practice and exposure.RESULTS
A total of 149 endovascular procedures were per-
formed in the studied period. These included 30 endovas-
cular aortic aneurysm repairs (EVARs), 58 angiographic
examinations with or without embolization (AGM), and
61 percutaneous artery angioplasty and stenting (PTA/S)
procedures. The operation time, fluoroscopy time, fluoros-
copy machine, and the application of radiation protection
devices for different types of endovascular procedures are
summarized in Table II.
The median yearly effective body dose (under lead
apron) of the surgeons was 0.20 mSv (range, 0.13 to 0.27
mSv). The median yearly effective doses were 0.19 mSv
(range, 0.10 to 0.33 mSv) for the eyes and 0.99 mSv
(range, 0.29 to 1.84 mSv) for the hands (Table III). All
surgeons’ annual body, eye, and hand effective doses were
well below the limit of occupational and public radiation
exposure recommended by the ICRP. The median yearly
effective body dose of the surgeons measured was only 1%
of the recommended limit. The respective mean body, eye,
and hand doses of the chief surgeon were 7.7 Sv, 9.7 Sv,
and 34.3 Sv per EVAR, 2.9 Sv, 2.4 Sv, and 11.4 Sv
for AGM, and 3.1 Sv, 2.0 Sv, and 20.8 Sv for PTA/S.
Vascular surgeons performing EVAR had the highest radi-
ation exposure to the body, eye, and hand. The average
radiation absorption of the patients who underwent EVAR,
AGM, and PTA/S were 12.7 mSv, 13.6 mSv, and 3.4 mSv,
respectively.
The average dose absorbed by the body and eye per
minute of fluoroscopy time of the four vascular surgeons as
chief operator in EVAR, AGM, and PTA/S were similar
(Tables IV, V, and VI); however, there was a greater
discrepancy on the average hand-absorbed dose among the
surgeons. When surgeon 1 was the chief operator, the
average hand dose per minute of fluoroscopy for PTA/S
was 2.5 Sv/min, whereas it was 8.43 mSv/min for sur-
geon 3. The similar discrepancy was observed between
surgeon 1 and 3 on the average hand-absorbed dose during
EVAR and AGM.
DISCUSSION
The number and variety of fluoroscopy-guided endo-
vascular procedures are ever increasing in many specialized
Table I. The safety dose limits for occupational and
public exposure with respect to different body areas
recommended by the International Commission on
Radiation Protection ICRP
Tissue or organ
Dose limit for
occupational worker Time period
Whole body 20 mSv/year* Averaged over 5 years
Lens of the eye 150 mSv/year In any calendar year
Extremities outside
lead apron 500 mSv/year In any calendar year
*Maximal 50 mSv in any one single year.vascular surgery centers.5 Radiation exposure of surgeons,
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ied. The finding of this study assured us that with proper
radiation protection, the yearly effective body, eye and
hand doses of vascular surgeons are within the safety dose
Table II. Operative details and protective devices applied
EVAR (n  30
Operating table 96.7% US Imagi
3.3% conventio
Fluoroscopy machine 96.7% OEC 980
3.3% BV 29‡
Mobile lead shield 100%
Mean operation time (min) 234  8
Mean fluoroscopy time (min) 13.0  7.5
Cumulative fluoroscopy time (min) 390
EVAR, Endovascular aneurysm repair; AMG, arteriogram with or with emb
*US Imaging Tables, New York, NY.
†GE Medical Systems, Salt Lake City, Utah.
‡Philips, Best, the Netherlands.
Table III. Summary of the application of personal radiatio
effective dose of all vascular surgeons
VS 1
No. of operations 71
Lead apron (%)
0.3 mm
0.5 mm 100
Thyroid shield (%) 100
Lead eyeglasses (%) 100
Role in operations (%)
Chief 64.8
Supervisor 32.4
First assistant 2.8
Second assistant
Cumulative fluoroscopy time (min) 684
Cumulative body absorbed dose (mSv) 0.20
Cumulative eye absorbed dose (mSv) 0.19
Cumulative hand absorbed dose (mSv) 1.18
VS, Vascular surgeons; TR, trainee.
Table IV. The average radiation absorbed dose per
minute fluoroscopy for individual surgeon performing as
chief operator during endovascular aneurysm repair
EVAR VS 1 VS 2 VS 3 VS 4
Total fluoroscopy time 235 116 50 NA
Average dose absorbed
(Sv/min)*
Body 0.21 1.55 0 NA
Eye 0.64 0.76 1.00 NA
Hand 1.96† 2.50 5.60† NA
EVAR, Endovascular aneurysm repair; VS, Vascular surgeons; NA, not
applicable.
*Dose per minute of fluoroscopy time.
†The greatest difference between various surgeons.limit recommended by the ICRP.4 Although the methodof measurement of radiation exposure is not exactly the
same, the annual effective dose of vascular surgeons is
relatively low compared with cardiologists and interven-
tional radiologists, who respectively received annual body
doses of 1.9 to 37 mSv6,7 and 0.37 to 10.1 mSv,8,9 The
fferent types of endovascular procedures
AMG (n  58) PTA/S (n  61)
94.4% US
Imaging*
91.1% US Imaging*
5.6%
conventional
8.9% conventional
98.1% OEC 9800† 91.7% OEC 9800†
1.9% BV 29‡ 8.3% BV 29‡
98.1% 95.0%
78  63 98  44
6.0  4.6 6.3  3.9
356 386
ion; PTA/S, percutaneous angioplasty with stenting.
otective devices and the annual body, eye and hand
VS 2 VS 3 VS 4 TR
78 70 66 76
1.3
00 100 100 98.7
00 98.6 100 97.4
9.0 0 10.6 0
30.8 41.4 37.9 32.9
44.9 14.3
23.1 38.6 40.9 32.9
1.2 5.7 21.2 34.2
20 544 528 598
0.27 0.27 0.13 0.14
0.33 0.20 0.10 0.10
0.99 1.84 0.72 0.29
Table V. The average radiation dose absorbed per
minute of fluoroscopy for individual surgeon performing
arteriograms as chief operator
AGM VS 1 VS 2 VS 3 VS 4
Total fluoroscopy time 154 37 54 58
Average dose absorbed
(Sv/min)*
Body 0.26 0 1.73 0.36
Eye 0.06 0.57 1.15 1.07
Hand 0.79† 3.14 5.00† 2.14
AGM, Arteriogram; VS, vascular surgeon.
*Dose per minute of fluoroscopy.
†The greatest difference between various surgeons.in di
)
ng*
nal
0†
olizatn pr
1
1
6median annual body effective dose of vascular surgeons in
JOURNAL OF VASCULAR SURGERY
September 2007458 Ho et althis study of 0.20 Sv will be approximately equivalent to
the dose a frequent flyer absorbed with two to three round
trip trans-Atlantic flights.
From these results, we can extrapolate that a vascular
surgeon can use fluoroscopy for 113,200 minutes or 49.4
days per year before reaching the dose limit recommended
by ICRP. Assuming similar fluoroscopy setting and radia-
tion protection devices were applied and calculated from
the mean body dose per procedure, a vascular surgeon
would have to perform 2597 EVAR, 6897 AGM, or 6451
PTA/S before reaching the dose limit; therefore, vascular
surgeons are unlikely to receive radiation exceeding the
limit, even with an increased workload.
This study found the patients’ average radiation dose
was 3.4 to 13.6 mSv, which is comparable to that of
percutaneous coronary angioplasty and stenting (range, 5.7
to 15.3 mSv)10 and embolization of intracranial arterio-
venous malformations (range, 6 to 43 mSv).11 Aneurysm
patients will require further surveillance computed tomog-
raphy assessment at intervals after EVAR, however, and
thus their cumulative radiation exposure will therefore in-
crease.12 Patients’ radiation dose will be further increased
with the development of more complicated fenestrated
stent graft devices that will require longer fluoroscopy time
for placement. Radiation exposure of this group of patients
should be monitored to ensure their safety.
High-dose ionizing radiation (10 Sv) can cause death
when given within a short period of time. At sublethal
doses, it can induce deterministic (skin burn, marrow sup-
pression, subfertility, cataract) and stochastic effects (hair
loss, carcinogenesis, teratogenesis). These adverse effects of
ionizing radiation were based on studies of high-dose ex-
posure in the range of tens to hundreds of microsiev-
erts.13-15 In real life medical practice with protection de-
vices, the radiation exposure is usually much lower.
Whether low-dose radiation will give rise to these adverse
effects is uncertain, but there is a concern that a stochastic
event may occur after long-term exposure. Even knowing a
surgeon’s annual effective dose is within the limits recom-
mended by the ICRP, one should still pursue additional
means to further reduce the radiation dose exposure, if
Table VI. The average radiation dose absorbed per
minute fluoroscopy for individual surgeon performing
percutaneous angioplasty and stenting as chief operator
PTA/S VS 1 VS 2 VS 3 VS 4
Total fluoroscopy time 49 35 71 82
Average dose absorbed
(Sv/min)*
Body 0.42 2.06 0.57 0.25
Eye 0 2.06 0.71 0
Hand 2.50† 5.59 8.43† 3.83
PTA/S, Percutaneous angioplasty and stenting; VS, vascular surgeon.
*Dose per minute of fluoroscopy.
†The greatest difference between various surgeons.possible.Lipsitz et al16 reported three vascular surgeons per-
forming EVAR during a 1-year interval (47 total proce-
dures, 1852 minutes of cumulative fluoroscopy time) had
an effective eye and hand dose of 2.04 to 7.77 mSv and
5.44 to 18.69mSv, respectively. These dosages were higher
than those recorded for the surgeons of the current study,
who performed 30 EVAR, 58 AGM, and 61 PTA/S (yearly
cumulative fluoroscopy time, 1132 minutes), even after
adjusted for the longer fluoroscopy time. This might be
related to the use of extra protective device, including a
table-side lead shield and a mobile lead shield, which would
reduce scattered radiation (Fig).
We observed a relatively large difference in the hand
radiation absorption per minute of fluoroscopy (range,
2.50 to 8.43 Sv/min) among the four surgeons. This
discrepancy was in evidence even for different types of
endovascular procedure, and therefore is likely a reflection
of their catheter and guidewire handling. It would be
interesting in future study to perform practice analysis by
recording the surgeon’s hand position with photographs or
video compared with the dose measurement. Surgeons
who had a high hand dose per minute of fluoroscopy time
could try to reduce excessive screening while maneuvering.
Alternatively, radiation protection gloves could be used,
which could effectively reduce half of the radiation.17
Vascular surgeon 1 applied lead eyeglasses in 100% of
his endovascular procedures, and surgeons 2 and 4 used eye
protection intermittently (9.0% and 10.6% of the time).
Surgeon 3 did not use lead eyeglasses at all and had higher
eye radiation absorption per minute of fluoroscopy than
surgeon 1 in the three types of endovascular procedures.
The averaged eye dose per minute fluoroscopy for all
procedures of surgeons 1 to 4 was 0.34, 0.96, 0.93, and
0.44 Sv/min, respectively. Thus, we believe lead eye-
glasses are beneficial to shield off radiation to the eye, but
other factors, including positioning of the mobile lead
shield, may contribute to reduce radiation exposure to
Fig. Photograph shows a mobile lead shield being applied to
shield operating surgeons from scattered radiation from the fluo-
roscopy machine.surgeon’s eye.
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for guidance of endovascular procedures, including
ultrasound-guided peripheral artery angioplasty18 and
MRI-guided EVAR.19 As these new image modalities be-
come more popular, the absorption of ionizing radiation
will be further reduced.
CONCLUSION
With the proper application of radiation protection
devices, the annual effective body, eye, and hand dose of
vascular surgeons who perform endovascular procedures
does not exceed the safety limits recommended by the
ICRP. There is a large variation in individual hand doses
that is likely related to individual endovascular techniques.
Patients who underwent endovascular procedures received
radiation doses similar to other fluoroscopically guided
procedures.
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